telotristat ethyl
Showing 1 - 25 of 158
Locally Advanced Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Houston (Placebo Administration, Questionnaire
Recruiting
- Locally Advanced Neuroendocrine Neoplasm
- Metastatic Neuroendocrine Neoplasm
- Placebo Administration
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 31, 2023
Neuroendocrine Tumors Trial (Telotristat Ethyl Oral Tablet)
Withdrawn
- Neuroendocrine Tumors
- Telotristat Ethyl Oral Tablet
- (no location specified)
Dec 3, 2021
Neuroendocrine Tumors, Carcinoid Syndrome, Diarrhea Trial in Iowa City (Telotristat ethyl, Peptide Receptor Radionuclide
Withdrawn
- Neuroendocrine Tumors
- +2 more
- Telotristat ethyl
- +2 more
-
Iowa City, IowaUniversity of Iowa Hospital and Clinics
Feb 9, 2022
Advanced Neuroendocrine Tumor, Carcinoid Syndrome Trial (Retifanlimab, Telotristat Ethyl)
Withdrawn
- Advanced Neuroendocrine Neoplasm
- Carcinoid Syndrome
- Retifanlimab
- Telotristat Ethyl
- (no location specified)
Sep 23, 2021
Biliary Tract Cancer Trial in United States (telotristat ethyl)
Terminated
- Biliary Tract Cancer
- telotristat ethyl
-
Gilbert, Arizona
- +13 more
Jan 14, 2022
Carcinoid Syndrome, Metastatic Nonfunctional Well Differentiated Neuroendocrine Tumor Trial in Detroit (other, procedure, drug)
Recruiting
- Carcinoid Syndrome
- Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm
- Carbon C 11 Alpha-methyltryptophan
- +3 more
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Mar 30, 2022
Analyze Effect of Telotristat Ethyl on Weight Regulation/Gain
Withdrawn
- Pancreatic Cancer
- +2 more
- telotristat ethyl
- (no location specified)
Dec 29, 2020
Small Intestinal NET, Carcinoid Heart Disease Trial (Telotristat Ethyl, Lanreotide)
Withdrawn
- Small Intestinal NET
- Carcinoid Heart Disease
- Telotristat Ethyl
- Lanreotide
- (no location specified)
Jan 30, 2020
Hepatic Impairment Trial in Miami, Orlando, San Antonio (Telotristat Ethyl)
Completed
- Hepatic Impairment
- Telotristat Ethyl
-
Miami, Florida
- +2 more
Oct 11, 2018
Drug-drug Interaction Trial in Dallas (Omeprazole 40 MG, Famotidine 40 mg, Telotristat ethyl 250 mg)
Completed
- Drug-drug Interaction
- Omeprazole 40 MG
- +2 more
-
Dallas, TexasCovance Clinical Research Unit
Apr 23, 2018
Neuroendocrine Tumors Trial in Lexington (Telotristat (Low-Dose), Telotristat (High-Dose))
Recruiting
- Neuroendocrine Tumors
- Telotristat (Low-Dose)
- Telotristat (High-Dose)
-
Lexington, KentuckyMarkey Cancer Center
Nov 10, 2022
Healthy Trial in Overland Park (Rodatristat Ethyl, Moxifloxacin, Placebo for Rodatristat)
Recruiting
- Healthy
- Rodatristat Ethyl
- +3 more
-
Overland Park, KansasAltasciences Clinical Kansas, Inc.
Jul 5, 2023
Healthy Trial in Austin (Rodatristat Ethyl, Placebo)
Completed
- Healthy
- Rodatristat Ethyl
- Placebo
-
Austin, TexasPPD Development
Jan 25, 2023
Irreversible Pulpitis Trial in Karachi (Ethyl chloride, Honey)
Completed
- Irreversible Pulpitis
- Ethyl chloride
- Honey
-
Karachi, Sindh, PakistanHira Danish
Oct 29, 2022
Cardiovascular Diseases Trial in Worldwide (AMR101, Placebo, Statin therapy)
Pulmonary Arterial Hypertension Trial in Worldwide (rodatristat ethyl 300 mg tablet BID, rodatristat ethyl 600 mg BID, Placebo)
Recruiting
- Pulmonary Arterial Hypertension
- rodatristat ethyl 300 mg tablet BID
- +2 more
-
Phoenix, Arizona
- +59 more
Jul 11, 2022
Hypertriglyceridemia Trial in Changsha (Placebo, Ethyl Icosapentate)
Recruiting
- Hypertriglyceridemia
- Placebo
- Ethyl Icosapentate
-
Changsha, ChinaMochida Investigational sites
Jun 9, 2022
Colorectal Cancer, Lynch Syndrome Trial in Kansas City (Omega-3 fatty acid ethyl esters (2 gram))
Active, not recruiting
- Colorectal Cancer
- Lynch Syndrome
- Omega-3 fatty acid ethyl esters (2 gram)
-
Kansas City, KansasThe University of Kansas Cancer Center, Westwood Campus
Nov 7, 2022
Coronavirus Disease Trial in Princeton
Completed
- Coronavirus Disease
-
Princeton, New JerseyGlobal Clinical Trials, LLC,
Mar 2, 2023
People of South Asian Descent With Atherosclerotic
Active, not recruiting
- Cardiovascular Diseases
- +3 more
-
Ajax, Ontario, Canada
- +4 more
Apr 25, 2022
Pain, Symptomatic Irreversible Pulpitis Trial in Karachi (Ethyl chloride, 5% lidocaine gel)
Completed
- Pain
- Symptomatic Irreversible Pulpitis
- Ethyl chloride
- 5% lidocaine gel
-
Karachi, Sindh, PakistanHira Danish
Aug 21, 2022
Healthy Trial in Madison (Radio-labeled rodatristat ethyl 600 mg)
Completed
- Healthy
- Radio-labeled rodatristat ethyl 600 mg
-
Madison, WisconsinCovance Clinical Research Unit
Jul 12, 2022
COVID-19, Inflammatory Response Trial in Toronto (Icosapent ethyl)
Completed
- COVID-19
- Inflammatory Response
- Icosapent ethyl
-
Toronto, Ontario, CanadaNorth York Diagnostic and Cardiology Clinic
Dec 21, 2021